TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Martin Dahl Medtech AB
Closing information (x1000 EUR)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
78
|
128
|
0 |
| Financial expenses |
0
|
0
|
0 |
| Earnings before taxes |
4
|
107
|
0 |
| EBITDA |
4
|
107
|
0 |
| Total assets |
95
|
114
|
0 |
| Current assets |
92
|
114
|
0 |
| Current liabilities |
52
|
24
|
2 |
| Equity capital |
41
|
84
|
-2 |
| - share capital |
4
|
5
|
4 |
| Employees (average) |
1
|
1
|
0 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
43.2%
|
73.7% | |
| Turnover per employee |
78
|
128 | |
| Profit as a percentage of turnover |
5.1%
|
83.6% | |
| Return on assets (ROA) |
4.2%
|
93.9% | |
| Current ratio |
176.9%
|
475.0%
|
0% |
| Return on equity (ROE) |
9.8%
|
127.4%
|
0% |
| Change turnover |
-46
|
128
|
0 |
| Change turnover % | -37% | ||
| Chg. No. of employees |
0
|
1
|
0 |
| Chg. No. of employees % | 0% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.